Update on Encapsulated Cell Technology

David Boyer MD, Jonathan L. Prenner, MD

Show Description +

David Boyer, MD, of Retina-Vitreous Associates Medical Group in Los Angeles, provides an update on encapsulated cell technology and the implications it has for the management of macular degeneration.

Posted: 10/14/2014

Keywords:

Retina Subspecialty Day

Up Next

Name: Update on Encapsulated Cell Technology
Uploaded: 2014-10-14T15:37:00+00:00
Description: David Boyer, MD, of Retina-Vitreous Associates Medical Group in Los Angeles, provides an update on encapsulated cell technology and the implications it has for the management of macular degeneration.

Outpatient Ophthalmic Surgery Society Update

Mark Kontos, MD, Y. Ralph Chu MD

Widefield Imaging

Nikolas J.S. London, MD, Szilard Kiss, MD

Intraoperative OCT

Justis Ehlers, MD, Nikolas J.S. London, MD

Preview - What to Watch for in Chicago!

iDEAL Phase 2 Study of Intravitreal iCo-007 for Diabetic Macular Edema

Nikolas J.S. London, MD, Quan Dong Nguyen, MD

Toric IOL Alignment

Robert Weinstock MD, Terry Kim, MD

Hyperopic LASIK

A. John Kanellopoulos, MD, Mark Kontos, MD

Diagnostic Testing and Evaluation in Cataract Surgery and Astigmatic Correction

Jonathan D. Solomon, MD, Mark Kontos, MD

The Use of Omidria in Cataract Surgery

John A. Hovanesian MD, Mark Kontos, MD

How I Came to Believe the EMR is Good for My Practice and Good for Patients: a Converted Skeptic

Jonathan Myers, MD, Robert Weinstock MD

Key Outcomes of SAKURA 1: A Phase 3 Study of Intravitreal Sirolimus for Noninfectious Posterior Segment Uveitis

Nikolas J.S. London, MD, Quan Dong Nguyen, MD

Managing Patient Expectations Following Premium IOL Placement

Kendall Donaldson, MD, Mark Kontos, MD

Comparison of Depth of Focus and Mesopic Contrast Sensitivity in Small-Aperture Corneal Inlay, Accommodating IOL, and Multifocal IOL Patients

Robert Weinstock MD, Jay S. Pepose, MD, PhD

Selective Laser Trabeculoplasty: Basic Principles and Pearls for Practice

Mark Kontos, MD, Kaweh Mansouri, MD

$PiXL™ for Refractive Correction$

PiXL™ for Refractive Correction

A. John Kanellopoulos, MD, Mark Kontos, MD

Femtosecond Cataract Innovations

Burkhard Dick, MD, Christopher Starr, MD

Toric IOLs in Corneal Disease

Christopher Starr, MD, Sheri Rowen, MD

MEAD: Diabetic Macular Edema Trial Subanalysis

Nikolas J.S. London, MD, Anat Lowenstein, MD

Third-World Cataracts in a First-World Setting

Steven D. Vold, MD, Ashvin Agarwal, MD

Dropless Cataract Surgery

Mark Kontos, MD, William Trattler, MD

Residual Astigmatism After IOL Placement

Mark Kontos, MD, John Berdahl, MD

$Improving Outcomes in Refractive Cataract Surgery With Intraoperative Aberrometry Utilizing Streaming Refractive Data$

Improving Outcomes in Refractive Cataract Surgery With Intraoperative Aberrometry Utilizing Streaming Refractive Data

Mark Kontos, MD, Samuel Masket MD

$Refractive Outcomes in Postrefractive Surgery Eyes Undergoing Cataract Surgery With Toric IOL Implantation Guided By Intraoperative Aberrometry$

Refractive Outcomes in Postrefractive Surgery Eyes Undergoing Cataract Surgery With Toric IOL Implantation Guided By Intraoperative Aberrometry

Mark Kontos, MD, P. Dee G. Stephenson, MD, FACS

Back to All Videos

Update on Encapsulated Cell Technology

David Boyer MD, Jonathan L. Prenner, MD

David Boyer, MD, of Retina-Vitreous Associates Medical Group in Los Angeles, provides an update on encapsulated cell technology and the implications it has for the management of macular degeneration.

Posted: 10/14/2014

Keywords:

Retina Subspecialty Day

Please log in to leave a comment.

Meeting Coverage:

American Academy of Ophthalmology

Update on Encapsulated Cell Technology

Up Next

Update on Encapsulated Cell Technology

More From AAO: 2014 Coverage